243 related articles for article (PubMed ID: 3994170)
1. Activated clotting time for control of anticoagulation during surgery.
Lefemine AA; Lewis M
Am Surg; 1985 May; 51(5):274-8. PubMed ID: 3994170
[TBL] [Abstract][Full Text] [Related]
2. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
[TBL] [Abstract][Full Text] [Related]
3. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
4. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery.
Babka R; Colby C; El-Etr A; Pifarré R
J Thorac Cardiovasc Surg; 1977 May; 73(5):780-2. PubMed ID: 850438
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass.
Arén C; Feddersen K; Rådegran K
J Thorac Cardiovasc Surg; 1987 Oct; 94(4):539-41. PubMed ID: 3309479
[TBL] [Abstract][Full Text] [Related]
8. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
Kessler G; Grünes G
Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
Dercksen SJ; Linssen GH
Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
[TBL] [Abstract][Full Text] [Related]
10. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system.
El Rouby S; Rinehart K; Zucker ML; LaDuca FM
J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423
[TBL] [Abstract][Full Text] [Related]
11. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of heparin concentration and activated clotting time monitoring (HEPCON HMS) system].
Sakurada T; Kikuchi Y; Koushima R; Nakashima S; Hachiro Y; Kagaya H
Nihon Kyobu Geka Gakkai Zasshi; 1997 Jun; 45(6):836-40. PubMed ID: 9217380
[TBL] [Abstract][Full Text] [Related]
13. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T
Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
[TBL] [Abstract][Full Text] [Related]
14. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
Bull BS; Huse WM; Brauer FS; Korpman RA
J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
[TBL] [Abstract][Full Text] [Related]
15. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
16. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
Daudt CA; Pereira SN; Moraes LB; Costa PS; Deboni LM; Figueiredo MS
Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
[TBL] [Abstract][Full Text] [Related]
17. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
18. Activated clotting time monitoring of intraoperative heparinization: our experience and comparison of two techniques.
Mabry CD; Thompson BW; Read RC; Campbell GS
Surgery; 1981 Nov; 90(5):889-95. PubMed ID: 7302842
[TBL] [Abstract][Full Text] [Related]
19. Successful use of a reduced dose of protamine after cardiopulmonary bypass.
Guffin AV; Dunbar RW; Kaplan JA; Bland JW
Anesth Analg; 1976; 55(1):110-3. PubMed ID: 1108703
[TBL] [Abstract][Full Text] [Related]
20. Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass.
Gautam NK; Schmitz ML; Harrison D; Zabala LM; Killebrew P; Belcher RH; Prodhan P; McKamie W; Norvell DC
Paediatr Anaesth; 2013 Mar; 23(3):233-41. PubMed ID: 23279140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
